Cover Image

Modified dose of guselkumab for treatment of pyoderma gangrenosum

Saved in:

Bibliographic Details
Main Authors:	Ashley M. Reese, BS (Author), Katherine Erickson, MD (Author), Katherine B. Reed, MD (Author), Alex G. Ortega-Loayza, MD, MCR (Author)
Format:	Book
Published:	Elsevier, 2022-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Guselkumab as a treatment option for recalcitrant pyoderma gangrenosum
by: Cassandra Baier, MS, PA-C, et al.
Published: (2021)

Multilesional pyoderma gangrenosum is associated with longer healing times and higher rates of underlying comorbidities: A single-center prospective registry study
by: Hannah Zhao, BA, et al.
Published: (2023)

Treatment of pyoderma gangrenosum with apremilast monotherapy
by: Zachary A. Bordeaux, BS, et al.
Published: (2022)

Spesolimab use in treatment of pyoderma gangrenosum
by: Sophie H. Guénin, MSc, et al.
Published: (2023)

Progression of pyoderma gangrenosum with angioinvasive fungus
by: Delice Kayishunge, BS, et al.
Published: (2021)

Recalcitrant Pyoderma Gangrenosum: Clinical Burden and Unmet Needs
by: Becker SL, et al.
Published: (2023)

LPIN2 gene mutation in a patient with overlapping neutrophilic disease (pyoderma gangrenosum and aseptic abscess syndrome)
by: Angelo V. Marzano, MD, et al.
Published: (2018)

Pyoderma gangrenosum in a patient on ixekizumab
by: Ilana R. Pollack, MSc, et al.
Published: (2021)

Pyoderma gangrenosum: a review with special emphasis on Latin America literature,
by: Milton José Max Rodríguez-Zúñiga, et al.
Published: (2020)

Pyoderma gangrenosum faciale in a patient with Crohn's disease
by: Timothy Arleo, BS, et al.
Published: (2020)

Cutaneous polyarteritis nodosa with clinical features of pyoderma gangrenosum
by: Juliana Pineider, BS, et al.
Published: (2020)

Novel use of apremilast for adjunctive treatment of recalcitrant pyoderma gangrenosum
by: Mary E. Laird, BA, et al.
Published: (2017)

Rapid resolution of pyoderma gangrenosum with brodalumab therapy
by: Michael W. Tee, MD, et al.
Published: (2020)

Pyoderma gangrenosum: Readability and quality of online health resources
by: Natalie M. Villa, MD, et al.
Published: (2021)

Pyoderma Gangrenosum
by: Krishnan S G S, et al.
Published: (1997)

Resolution of therapy-resistant pyoderma gangrenosum with upadacitinib
by: Lisa Van Eycken, MD, et al.
Published: (2023)

Pyoderma gangrenosum developing in a patient treated with dupilumab
by: Jessica Nasseh, MD, et al.
Published: (2022)

Pyoderma gangrenosum in pregnancy successfully treated with infliximab and prednisone
by: Julia D. Stiegler, MD, et al.
Published: (2017)

Granulomatosis with polyangiitis with pyoderma gangrenosum, acne, hidradenitis suppurativa-like features
by: Rebeka Dejenie, BS, et al.
Published: (2024)

Plasmablastic-like lymphoma arising within chronic pyoderma gangrenosum
by: Elaine Dupuis, MD, MBA, et al.
Published: (2017)

Pyoderma gangrenosum induced by secukinumab in a patient with psoriasis successfully treated with ustekinumab
by: Amy J. Petty, BS, et al.
Published: (2020)

Pyoderma gangrenosum: An update
by: Ramesh M Bhat
Published: (2012)

Childhood pyoderma gangrenosum
by: Mayur Ranu Bhobe, et al.
Published: (2017)

Childhood pyoderma gangrenosum
by: Mayur Ranu Bhobe, et al.
Published: (2017)

Recalcitrant vulvar pyoderma gangrenosum successfully treated with mycophenolate mofetil
by: Kelly Z. Young, BA, et al.
Published: (2022)

A case of primarily facial pyoderma gangrenosum associated with Takayasu arteritis
by: Ken Okamura, MD, PhD, et al.
Published: (2017)

Pyoderma Gangrenosum - Variants And Associations
by: Sentamilselvi G, et al.
Published: (2002)

Painful linear ulcers: A case of cutaneous sporotrichosis mimicking pyoderma gangrenosum
by: Kristy Charles, MD, et al.
Published: (2017)

Novel topical cyclosporine as adjuvant therapy for pyoderma gangrenosum: A case series
by: Radhika Shah, MD, PharmD, et al.
Published: (2023)

Recalcitrant cutaneous pyoderma gangrenosum with pulmonary involvement resolved with treatment of underlying plasma cell dyscrasia
by: Tyler A. Hooton, MD, et al.
Published: (2021)

Intractable pyoderma gangrenosum in a Crohn's disease patient on vedolizumab
by: Jennifer E. Yeh, PhD, et al.
Published: (2017)

Nasal septal and mucosal disease associated with pyoderma gangrenosum in a cocaine user
by: Rahul Sehgal, MD, et al.
Published: (2017)

Pyoderma gangrenosum: problems related to the diagnostics and treatment
by: A. V. Patrushev, et al.
Published: (2017)

Treatment of pyoderma gangrenosum in pregnancy with certolizumab pegol
by: Lindsey J. Wanberg, et al.
Published: (2024)

Pathergy: implications for the treatment of Pyoderma Gangrenosum lesions
by: Iana Cibelly Moreira de Vasconcelos, Adriana Jorge Brandão, Janara Batista Cruz, Adelice Cangussu Oliveira Gois, Grazielle Roberta Freitas da Silva, Amanda Delmondes de Brito Fontenele Fernandes
Published: (2020)

Necrotizing Escherichia coli skin and soft tissue infection with malakoplakia-like features mimicking pyoderma gangrenosum
by: Alexander M. Hammond, BS, et al.
Published: (2021)

Pyoderma gangrenosum, acne, and hidradenitis suppurativa (PASH) syndrome with recurrent vasculitis
by: Dorene Niv, DO, et al.
Published: (2017)

Suppression of pathergy in pyoderma gangrenosum with infliximab allowing for successful tendon debridement
by: Paul A. Leiphart, BA, et al.
Published: (2018)

Pyoderma gangrenosum and anticardiolipin antibody
by: de Godoy Jose Maria, et al.
Published: (2006)

Ciprofloxacin induced pyoderma gangrenosum
by: M Kumaresan, et al.
Published: (2011)